Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
McKinsey
Mallinckrodt
Merck
Harvard Business School

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

AVONEX Drug Profile

See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for AVONEX

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Merck KGaA, Darmstadt, GermanyPhase 3
EMD Serono Research & Development Institute, Inc.Phase 3
CinnagenPhase 1

See all AVONEX clinical trials

Recent Litigation for AVONEX

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Amgen Inc. v. Accord Healthcare, Inc.2018-06-28
Idenix Pharmaceuticals LLC v. Gilead Sciences, Inc.2014-07-01

See all AVONEX litigation

Patent Text Search: US Patents for AVONEX

These patents were identified by searching patent claims

Supplementary Protection Certificates for AVONEX

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
CR 2016 00058 Denmark   Start Trial PRODUCT NAME: DACLIZUMAB; REG. NO/DATE: EU/1/16/1107 20160705
122016000098 Germany   Start Trial PRODUCT NAME: DACLIZUMAB; REGISTRATION NO/DATE: EU/1/16/1107 20160701
CA 2016 00058 Denmark   Start Trial PRODUCT NAME: DACLIZUMAB; REG. NO/DATE: EU/1/16/1107 20160705
122014000079 Germany   Start Trial PRODUCT NAME: SOFOSBUVIR UND PHARMAZEUTISCH AKZEPTABLE SALZE DAVON; REGISTRATION NO/DATE: EU/1/13/894 20140116
PA2014031 Lithuania   Start Trial PRODUCT NAME: SOFOSBUVIRUM; REGISTRATION NO/DATE: EU/1/13/894/1, 2014 01 16 EU/1/13/894/2 20140116
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Moodys
McKinsey
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.